General Information
Get notified when Genalyte, Inc. moves
Funding, new markets, leadership changes, hiring surges — one e-mail, only when something happens.
Track Genalyte, Inc.
Get real-time alerts for funding, hiring, news, and 40+ signal types.
See how it worksDiscover More
United States Market
Biotechnology
About Genalyte, Inc.
Taxonomy: diagnostic testing, laboratory services, serological testing, immunoassays, point-of-care testing, COVID-19 testing, technology-enabled healthcare, telehealth platform, FDA clearance, clinical diagnostics, cloud-based healthcare solutions
Funding Rounds & Investors (5)
View All| Funding Stage | Amount | Investors | Lead Investors | Date |
|---|---|---|---|---|
| Late Vc | •••••• | 5 |
|
01 Jan 2021 |
| Series D | •••••• | 2 |
|
01 Nov 2016 |
| Series C | •••••• | 5 |
|
01 Aug 2015 |
| Series B | •••••• | 1 |
|
01 Mar 2012 |
| Spinout | •••••• | 1 |
|
01 Jan 2007 |
Genalyte, Inc. Alternatives & Competitors
Patient-Centered. Doctor Fulfilling.
Diversifying patient/doctor connections through innovative technology.
FAQ About Genalyte, Inc.
Don't just browse. Track.
Signal Tracker monitors Genalyte, Inc. and millions of companies for funding rounds, hiring surges, product changes, and 40+ signal types — so you never miss an opportunity.